ADM collaborates with Qualitas Health release vegan DHA/EPA blends
Archer Daniels Midland Company, in collaboration with Qualitas Health, has unveiled a new line of Onavita Algal DHA and Almega EPA blends.
Photo © iStockphoto.com/Juxtagirl
Archer Daniels Midland Company (ADM; Chicago, IL), in collaboration with Qualitas Health (Houston, TX), has unveiled a new line of Onavita Algal DHA and Almega EPA blends. The three blends contain omega-3, 6, and 9 to support cognitive, heart, immune, and eye health. The products are made from renewable sources, and are entirely plant based.
“Today’s consumers are looking for ready-to-consume food and beverages that provide specific health benefits,” said Vikram Luthar, president, health and wellness, ADM, in a press release. “Our expansive array of plant-based omega-3s do just that.”
“Qualitas Health’s purpose is to create sustainable food solutions for everyone and our planet,” said Qualitas Health CEO Miguel Calatayud, in a press release. “Partnering with ADM is a significant step towards our goal of bringing sustainable ingredients into the global supply chain.”
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
